E-islet 01

异体人再生胰岛

Report date: 2026/01/21 13:48:33

Base Information

Drug NameE-islet 01
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Pancreatic islet cell therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAwarenessHypoglycemiaDiabetes Mellitus, Type 1 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSuzhou Zhixin Haozheng Regenerative Medicine Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesEndoCell Therapeutics IncSuzhou Zhixin Haozheng Regenerative Medicine Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsAwarenessHypoglycemiaDiabetes Mellitus, Type 1 +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A